Associate Director, Omnichannel Marketing
Iovance Biotherapeutics Inc - Remote
Posted Oct 15, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Nov 20, 2026
- Salary
- $200K-$215K From the posting source checked Nov 16, 2026
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Market context
- U.S. role benchmark (BLS OEWS)
- $93,011 U.S. median for this role
- Projected growth (BLS Employment Projections)
- +5.1% - Faster than average
U.S. benchmark only; posted salary is not compared across countries or currencies.
Matched to SOC 13-1161 - Marketing aggregate by role bucket.
Source:U.S. Bureau of Labor Statistics, OEWS, May 2024andEmployment Projections, 2024-2034.
Role
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Nov 16, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Associate Director, Omnichannel Marketing Remote About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The Iovance TIL platform spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit www.iovance.com . Amtagvi® and its accompanying design marks, Proleukin ® , Iovance ® , and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or ts subsidiaries. All other trademarks and registered trademarks are the property of their respective owners. Information on Iovance's broad, industry-leading patent portfolio is available on the Intellectual Property page on www.iovance.com . Overview The Associate Director, Omnichannel Marketing will lead integrated omnichannel planning, media investment, and non-personal promotion for healthcare professional (HCP), patient, and caregiver audiences. In partnership with HCP and Patient Marketing leads, this role translates brand strategy and customer insights into coordinated engagement plans across digital and media channels, with accountability for campaign delivery,
Read the full description at job-boards.greenhouse.io. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Associate Director, R&D and Commercial IT
Iovance Biotherapeutics Inc - Remote
Associate Director, International Marketing, Skin
Regeneron Pharmaceuticals - SLEEPY HOLLOW
Associate Director, Omnichannel Content Strategy & Operations
Revolution Medicines - Remote (United States)
Associate Director US Oncology Marketing, Patient Engagement Strategy - Individualized Neoantigen therapy
Merck & Co., Inc. - 3 Locations